| Year |
Citation |
Score |
| 2023 |
Giles MA, Cooper CM, Jha MK, Chin Fatt CR, Pizzagalli DA, Mayes TL, Webb CA, Greer TL, Etkin A, Trombello JM, Chase HW, Phillips ML, McInnis MG, Carmody T, Adams P, et al. Reward Behavior Disengagement, a Neuroeconomic Model-Based Objective Measure of Reward Pathology in Depression: Findings from the EMBARC Trial. Behavioral Sciences (Basel, Switzerland). 13. PMID 37622759 DOI: 10.3390/bs13080619 |
0.318 |
|
| 2022 |
Trombello JM, Cooper CM, Fatt CC, Grannemann BD, Carmody TJ, Jha MK, Mayes TL, Greer TL, Yezhuvath U, Aslan S, Pizzagalli DA, Weissman MM, Webb CA, Dillon DG, McGrath PJ, et al. Neural substrates of emotional conflict with anxiety in major depressive disorder: Findings from the Establishing Moderators and biosignatures of Antidepressant Response in Clinical Care (EMBARC) randomized controlled trial. Journal of Psychiatric Research. 149: 243-251. PMID 35290819 DOI: 10.1016/j.jpsychires.2022.03.015 |
0.313 |
|
| 2020 |
Chin Fatt CR, Cooper C, Jha MK, Aslan S, Grannemann B, Kurian B, Greer TL, Fava M, Weissman M, McGrath PJ, Parsey RV, Etkin A, Phillips ML, Trivedi MH. Dorsolateral Prefrontal Cortex and Subcallosal Cingulate Connectivity Show Preferential Antidepressant Response in Major Depressive Disorder. Biological Psychiatry. Cognitive Neuroscience and Neuroimaging. PMID 32921587 DOI: 10.1016/J.Bpsc.2020.06.019 |
0.439 |
|
| 2020 |
Killeen TK, Wolf B, Greer TL, Carmody T, Rethorst CD, Trivedi MH. Gender and racial/ethnic differences in physiologic responses in the Stimulant Reduction Intervention using Dosed Exercise Study. Addictive Behaviors. 110: 106546. PMID 32688225 DOI: 10.1016/J.Addbeh.2020.106546 |
0.391 |
|
| 2020 |
Greer TL, Walker R, Rethorst CD, Northrup TF, Warden D, Horigian VE, Silverstein M, Shores-Wilson K, Stotts AL, Trivedi MH. Identifying and responding to trial implementation challenges during multisite clinical trials. Journal of Substance Abuse Treatment. 112: 63-72. PMID 32220413 DOI: 10.1016/J.Jsat.2020.02.004 |
0.3 |
|
| 2019 |
Trivedi MH, Chin Fatt CR, Jha MK, Cooper CM, Trombello JM, Mason BL, Hughes J, Gadad BS, Czysz AH, Toll RT, Fuller AK, Sethuram S, Mayes TL, Minhajuddin A, Carmody T, ... Greer TL, et al. Comprehensive phenotyping of depression disease trajectory and risk: Rationale and design of Texas Resilience Against Depression study (T-RAD). Journal of Psychiatric Research. 122: 22-32. PMID 31918350 DOI: 10.1016/J.Jpsychires.2019.12.004 |
0.471 |
|
| 2019 |
Chin Fatt CR, Jha MK, Cooper CM, Fonzo G, South C, Grannemann B, Carmody T, Greer TL, Kurian B, Fava M, McGrath PJ, Adams P, McInnis M, Parsey RV, Weissman M, et al. Effect of Intrinsic Patterns of Functional Brain Connectivity in Moderating Antidepressant Treatment Response in Major Depression. The American Journal of Psychiatry. appiajp201918070870. PMID 31537090 DOI: 10.1176/Appi.Ajp.2019.18070870 |
0.388 |
|
| 2019 |
Vidot DC, Rethorst CD, Carmody TJ, Stoutenberg M, Walker R, Greer TL, Trivedi MH. Acute and long-term cannabis use among stimulant users: Results from CTN-0037 Stimulant Reduction Intervention using Dosed Exercise (STRIDE) Randomized Control Trial. Drug and Alcohol Dependence. 200: 139-144. PMID 31129484 DOI: 10.1016/J.Drugalcdep.2019.02.032 |
0.345 |
|
| 2019 |
Trivedi MH, Jha MK, Kahalnik F, Pipes R, Levinson S, Lawson T, Rush AJ, Trombello JM, Grannemann B, Tovian C, Kinney R, Clark EW, Greer TL. VitalSign: A Primary Care First (PCP-First) Model for Universal Screening and Measurement-Based Care for Depression. Pharmaceuticals (Basel, Switzerland). 12. PMID 31091770 DOI: 10.3390/Ph12020071 |
0.393 |
|
| 2019 |
Jha MK, Minhajuddin A, Chin-Fatt C, Greer TL, Carmody TJ, Trivedi MH. Sex differences in the association of baseline c-reactive protein (CRP) and acute-phase treatment outcomes in major depressive disorder: Findings from the EMBARC study. Journal of Psychiatric Research. 113: 165-171. PMID 30959227 DOI: 10.1016/J.Jpsychires.2019.03.013 |
0.407 |
|
| 2019 |
Jha M, Minhajuddin A, Fatt CC, Gadad B, Greer T, Trivedi M. S90. Association of Autoimmunity With Dysfunctional Th2-Mediated Immune Response in Major Depressive Disorder Biological Psychiatry. 85. DOI: 10.1016/J.Biopsych.2019.03.841 |
0.384 |
|
| 2019 |
Czysz A, Grannemann B, Mason B, Gadad B, Carmody T, Greer T, Scherer P, Trivedi M. T142. Insulin Resistance Impacts the Relationship of Depression Severity on Cognitive Control Biological Psychiatry. 85. DOI: 10.1016/J.Biopsych.2019.03.465 |
0.33 |
|
| 2019 |
Jha M, Minhajuddin A, Fatt CC, Trombello J, Mayes T, Greer T, Trivedi M. 224. Sex Differences in Association of Inflammation and Suicidality: Findings From Two Separate Cohorts of Patients With Major Depressive Disorder Biological Psychiatry. 85: S93. DOI: 10.1016/J.Biopsych.2019.03.238 |
0.417 |
|
| 2018 |
Harrison JE, Barry H, Baune BT, Best MW, Bowie CR, Cha DS, Culpepper L, Fossati P, Greer TL, Harmer C, Klag E, Lam RW, Lee Y, Mansur RB, Wittchen HU, et al. Stability, reliability, and validity of the THINC-it screening tool for cognitive impairment in depression: A psychometric exploration in healthy volunteers. International Journal of Methods in Psychiatric Research. e1736. PMID 30088298 DOI: 10.1002/Mpr.1736 |
0.36 |
|
| 2018 |
Trombello JM, Pizzagalli DA, Weissman MM, Grannemann BD, Cooper CM, Greer TL, Malchow AL, Jha MK, Carmody TJ, Kurian BT, Webb CA, Dillon DG, McGrath PJ, Bruder G, Fava M, et al. Characterizing anxiety subtypes and the relationship to behavioral phenotyping in major depression: Results from the EMBARC study. Journal of Psychiatric Research. 102: 207-215. PMID 29689518 DOI: 10.1016/J.Jpsychires.2018.04.003 |
0.42 |
|
| 2018 |
Carmody T, Greer TL, Walker R, Rethorst CD, Trivedi MH. A Complier Average Causal Effect Analysis of the Stimulant Reduction Intervention using Dosed Exercise Study. Contemporary Clinical Trials Communications. 10: 1-8. PMID 29682627 DOI: 10.1016/J.Conctc.2018.02.001 |
0.356 |
|
| 2018 |
Sanchez K, Killian MO, Mayes TL, Greer TL, Trombello JM, Lindblad R, Grannemann BD, Carmody TJ, Rush AJ, Walker R, Trivedi MH. A psychometric evaluation of the Concise Health Risk Tracking Self-Report (CHRT-SR)- a measure of suicidality-in patients with stimulant use disorder. Journal of Psychiatric Research. 102: 65-71. PMID 29626753 DOI: 10.1016/J.Jpsychires.2018.03.012 |
0.337 |
|
| 2018 |
Jha MK, Wakhlu S, Dronamraju N, Minhajuddin A, Greer TL, Trivedi MH. Validating pre-treatment body mass index as moderator of antidepressant treatment outcomes: Findings from CO-MED trial. Journal of Affective Disorders. 234: 34-37. PMID 29522941 DOI: 10.1016/J.Jad.2018.02.089 |
0.376 |
|
| 2018 |
Trombello JM, Killian MO, Liao A, Sanchez K, Greer TL, Walker R, Grannemann B, Rethorst CD, Carmody T, Trivedi MH. Psychometrics of the Self-Report Concise Associated Symptoms Tracking Scale (CAST-SR): Results From the STRIDE (CTN-0037) Study. The Journal of Clinical Psychiatry. 79. PMID 29325238 DOI: 10.4088/Jcp.17M11707 |
0.436 |
|
| 2018 |
Greer T, Jha M, Grannemann B, Minhajuddin A, Trivedi M. 156. Inflammation Selectively Impairs Executive Function in Treatment-Resistant Depressed Outpatients: Findings From TREAD Study Biological Psychiatry. 83: S63-S64. DOI: 10.1016/J.Biopsych.2018.02.174 |
0.408 |
|
| 2018 |
Fatt CC, Cooper C, Jha M, Fonzo G, Grannemann B, Aslan S, Greer T, Fava M, Phillips M, McGrath P, Adams P, Weissman M, Kurian B, Parsey R, McInnis M, et al. S131. Resting State Functional Connectivity Patterns Differentially Predict Treatment Outcomes to Sertraline Versus Placebo in Patients with Major Depressive Disorder Biological Psychiatry. 83: S398-S399. DOI: 10.1016/J.Biopsych.2018.02.1022 |
0.421 |
|
| 2018 |
Jha M, Wakhlu S, Dronamraju N, Minhajuddin A, Greer T, Trivedi M. S109. Pre-Treatment Body Mass Index (BMI) Differentially Predicts Treatment Outcomes With SSRI Monotherapy and Antidepressant Medication Combinations: Findings From CO-MED Trial Biological Psychiatry. 83. DOI: 10.1016/J.Biopsych.2018.02.1000 |
0.306 |
|
| 2017 |
McIntyre RS, Best MW, Bowie CR, Carmona NE, Cha DS, Lee Y, Subramaniapillai M, Mansur RB, Barry H, Baune BT, Culpepper L, Fossati P, Greer TL, Harmer C, Klag E, et al. The THINC-Integrated Tool (THINC-it) Screening Assessment for Cognitive Dysfunction: Validation in Patients With Major Depressive Disorder. The Journal of Clinical Psychiatry. 78: 873-881. PMID 28858441 DOI: 10.4088/Jcp.16M11329 |
0.395 |
|
| 2017 |
Greer TL, Furman JL, Trivedi MH. Evaluation of the benefits of exercise on cognition in major depressive disorder. General Hospital Psychiatry. PMID 28690019 DOI: 10.1016/J.Genhosppsych.2017.06.002 |
0.431 |
|
| 2017 |
Rethorst CD, South CC, Rush AJ, Greer TL, Trivedi MH. Prediction of treatment outcomes to exercise in patients with nonremitted major depressive disorder. Depression and Anxiety. PMID 28672073 DOI: 10.1002/Da.22670 |
0.494 |
|
| 2017 |
Cha DS, Carmona NE, Subramaniapillai M, Mansur RB, Lee Y, Hon Lee J, Lee J, Rosenblat JD, Shekotikhina M, Park C, Rong C, Greer TL, Lam R, Baune BT, Harrison J, et al. Cognitive impairment as measured by the THINC-integrated tool (THINC-it): Association with psychosocial function in major depressive disorder. Journal of Affective Disorders. 222: 14-20. PMID 28667888 DOI: 10.1016/J.Jad.2017.06.036 |
0.463 |
|
| 2017 |
Trombello JM, Carmody T, Greer TL, Walker R, Rethorst CD, Trivedi MH. Psychosocial relationship status and quality as predictors of exercise intervention adherence and substance use outcomes: Results from the STRIDE (CTN-0037) study. Psychiatry Research. 254: 332-339. PMID 28525788 DOI: 10.1016/J.Psychres.2017.04.062 |
0.309 |
|
| 2017 |
Sanchez K, Greer TL, Walker R, Carmody T, Rethorst CD, Trivedi MH. Racial and ethnic differences in treatment outcomes among adults with stimulant use disorders after a dosed exercise intervention. Journal of Ethnicity in Substance Abuse. 1-16. PMID 28524806 DOI: 10.1080/15332640.2017.1317310 |
0.392 |
|
| 2017 |
Greer TL, Thompson LT. Editorial: Eyeblink Classical Conditioning in Psychiatric Conditions: Novel Uses for a Classic Paradigm. Frontiers in Psychiatry. 8: 48. PMID 28396641 DOI: 10.3389/Fpsyt.2017.00048 |
0.532 |
|
| 2017 |
Jha MK, Teer RB, Minhajuddin A, Greer TL, Rush AJ, Trivedi MH. Daily activity level improvement with antidepressant medications predicts long-term clinical outcomes in outpatients with major depressive disorder. Neuropsychiatric Disease and Treatment. 13: 803-813. PMID 28352180 DOI: 10.2147/Ndt.S128407 |
0.448 |
|
| 2017 |
Trivedi MH, Greer TL, Rethorst CD, Carmody T, Grannemann BD, Walker R, Warden D, Shores-Wilson K, Stoutenberg M, Oden N, Silverstein M, Hodgkins C, Love L, Seamans C, Stotts A, et al. Randomized Controlled Trial Comparing Exercise to Health Education for Stimulant Use Disorder: Results From the CTN-0037 STimulant Reduction Intervention Using Dosed Exercise (STRIDE) Study. The Journal of Clinical Psychiatry. PMID 28199070 DOI: 10.4088/Jcp.15M10591 |
0.382 |
|
| 2017 |
Jha MK, Minhajuddin A, Gadad BS, Greer T, Grannemann B, Soyombo A, Mayes TL, Rush AJ, Trivedi MH. Can C-reactive protein inform antidepressant medication selection in depressed outpatients? Findings from the CO-MED trial. Psychoneuroendocrinology. 78: 105-113. PMID 28187400 DOI: 10.1016/J.Psyneuen.2017.01.023 |
0.4 |
|
| 2017 |
Jha M, Minhajuddin A, Gadad B, Greer T, Grannemann B, Rush AJ, Trivedi M. 36. Inflammatory Biomarkers as Viable Moderators of Selecting between SSRI and Bupropion in Depressed Outpatients Biological Psychiatry. 81: S15-S16. DOI: 10.1016/J.Biopsych.2017.02.047 |
0.4 |
|
| 2017 |
Jha M, Minhajuddin A, Neeland I, Greer T, Trivedi M. 34. Abdominal Adiposity is Associated with Higher Levels of Depression Severity, Cognitive Impairment and Markers of Inflammation and Insulin Resistance Biological Psychiatry. 81: S15. DOI: 10.1016/J.Biopsych.2017.02.045 |
0.33 |
|
| 2016 |
Jha MK, Minhajuddin A, Greer TL, Carmody T, Rush AJ, Trivedi MH. Early Improvement in Psychosocial Function Predicts Longer-Term Symptomatic Remission in Depressed Patients. Plos One. 11: e0167901. PMID 28030546 DOI: 10.1371/Journal.Pone.0167901 |
0.439 |
|
| 2016 |
Toups M, Carmody T, Greer T, Rethorst C, Grannemann B, Trivedi MH. Exercise is an effective treatment for positive valence symptoms in major depression. Journal of Affective Disorders. 209: 188-194. PMID 27936452 DOI: 10.1016/J.Jad.2016.08.058 |
0.433 |
|
| 2016 |
Warden D, Sanchez K, Greer T, Carmody T, Walker R, Dela Cruz A, Toups M, Rethorst C, Trivedi MH. Demographic and clinical characteristics of current comorbid psychiatric disorders in a randomized clinical trial for adults with stimulant use disorders. Psychiatry Research. 246: 136-141. PMID 27693866 DOI: 10.1016/J.Psychres.2016.09.007 |
0.373 |
|
| 2016 |
Northrup TF, Greer TL, Walker R, Rethorst CD, Warden D, Stotts AL, Trivedi MH. An ounce of prevention: A pre-randomization protocol to improve retention in substance use disorder clinical trials. Addictive Behaviors. 64: 137-142. PMID 27610591 DOI: 10.1016/J.Addbeh.2016.08.040 |
0.319 |
|
| 2016 |
Suterwala AM, Rethorst CD, Carmody TJ, Greer TL, Grannemann BD, Jha M, Trivedi MH. Affect Following First Exercise Session as a Predictor of Treatment Response in Depression. The Journal of Clinical Psychiatry. 77: 1036-1042. PMID 27561137 DOI: 10.4088/Jcp.15M10104 |
0.461 |
|
| 2016 |
Jha MK, Minhajuddin A, Greer TL, Carmody T, Rush AJ, Trivedi MH. Early Improvement in Work Productivity Predicts Future Clinical Course in Depressed Outpatients: Findings From the CO-MED Trial. The American Journal of Psychiatry. appiajp201616020176. PMID 27523501 DOI: 10.1176/Appi.Ajp.2016.16020176 |
0.44 |
|
| 2016 |
Jha MK, Greer TL, Grannemann BD, Carmody T, Rush AJ, Trivedi MH. Early normalization of Quality of Life predicts later remission in depression: Findings from the CO-MED trial. Journal of Affective Disorders. 206: 17-22. PMID 27455354 DOI: 10.1016/J.Jad.2016.07.012 |
0.373 |
|
| 2016 |
Greer TL, Trombello JM, Rethorst CD, Carmody TJ, Jha MK, Liao A, Grannemann BD, Chambliss HO, Church TS, Trivedi MH. IMPROVEMENTS IN PSYCHOSOCIAL FUNCTIONING AND HEALTH-RELATED QUALITY OF LIFE FOLLOWING EXERCISE AUGMENTATION IN PATIENTS WITH TREATMENT RESPONSE BUT NONREMITTED MAJOR DEPRESSIVE DISORDER: RESULTS FROM THE TREAD STUDY. Depression and Anxiety. PMID 27164293 DOI: 10.1002/Da.22521 |
0.453 |
|
| 2016 |
Rethorst CD, Tu J, Carmody TJ, Greer TL, Trivedi MH. Atypical depressive symptoms as a predictor of treatment response to exercise in Major Depressive Disorder. Journal of Affective Disorders. 200: 156-158. PMID 27136412 DOI: 10.1016/J.Jad.2016.01.052 |
0.509 |
|
| 2016 |
Dela Cruz AM, Carmody T, Greer TL, Rethorst CD, Warden D, Walker R, Trivedi MH. Baseline medical comorbidities in adults randomized in the STRIDE trial for psychostimulant use disorders. The American Journal On Addictions / American Academy of Psychiatrists in Alcoholism and Addictions. PMID 26991889 DOI: 10.1111/Ajad.12363 |
0.398 |
|
| 2015 |
Rethorst CD, Greer TL, Toups MS, Bernstein I, Carmody TJ, Trivedi MH. IL-1β and BDNF are associated with improvement in hypersomnia but not insomnia following exercise in major depressive disorder. Translational Psychiatry. 5: e611. PMID 26241349 DOI: 10.1038/Tp.2015.104 |
0.356 |
|
| 2015 |
Nakonezny PA, Morris DW, Greer TL, Byerly MJ, Carmody TJ, Grannemann BD, Bernstein IH, Trivedi MH. Evaluation of anhedonia with the Snaith-Hamilton Pleasure Scale (SHAPS) in adult outpatients with major depressive disorder. Journal of Psychiatric Research. 65: 124-30. PMID 25864641 DOI: 10.1016/J.Jpsychires.2015.03.010 |
0.382 |
|
| 2015 |
Chartier KG, Sanchez K, Killeen TK, Burrow A, Carmody T, Greer TL, Trivedi MH. Men and women from the STRIDE clinical trial: An assessment of stimulant abstinence symptom severity at residential treatment entry. The American Journal On Addictions / American Academy of Psychiatrists in Alcoholism and Addictions. 24: 336-40. PMID 25694201 DOI: 10.1111/Ajad.12190 |
0.32 |
|
| 2015 |
Sanchez K, Chartier KG, Greer TL, Walker R, Carmody T, Rethorst CD, Ring KM, Dela Cruz AM, Trivedi MH. Comorbidities and race/ethnicity among adults with stimulant use disorders in residential treatment. Journal of Ethnicity in Substance Abuse. 14: 79-95. PMID 25580933 DOI: 10.1080/15332640.2014.961109 |
0.368 |
|
| 2015 |
Greer TL, Grannemann BD, Chansard M, Karim AI, Trivedi MH. Dose-dependent changes in cognitive function with exercise augmentation for major depression: results from the TREAD study. European Neuropsychopharmacology : the Journal of the European College of Neuropsychopharmacology. 25: 248-56. PMID 25453481 DOI: 10.1016/J.Euroneuro.2014.10.001 |
0.396 |
|
| 2015 |
Sanchez K, Chartier KG, Greer TL, Walker R, Carmody T, Rethorst CD, Ring KM, dela Cruz A, Trivedi MH. Race and ethnicity differences among adults with stimulant use disorders in a residential treatment setting: A baseline analysis of the stride cohort Drug and Alcohol Dependence. 146: e88. DOI: 10.1016/J.Drugalcdep.2014.09.608 |
0.323 |
|
| 2014 |
Walker R, Morris DW, Greer TL, Trivedi MH. Research staff training in a multisite randomized clinical trial: Methods and recommendations from the Stimulant Reduction Intervention using Dosed Exercise (STRIDE) trial. Addiction Research & Theory. 22: 407-415. PMID 25379036 DOI: 10.3109/16066359.2013.868446 |
0.355 |
|
| 2014 |
Sanchez K, Walker R, Campbell AN, Greer TL, Hu MC, Grannemann BD, Nunes EV, Trivedi MH. Depressive Symptoms and Associated Clinical Characteristics in Outpatients Seeking Community-Based Treatment for Alcohol and Drug Problems. Substance Abuse. 1-7. PMID 25084694 DOI: 10.1080/08897077.2014.937845 |
0.461 |
|
| 2014 |
Rethorst CD, Greer TL, Grannemann B, Ring KM, Marcus BH, Trivedi MH. A Health Education Intervention as the Control Condition in the CTN-0037 STRIDE multi-site exercise trial: Rationale and Description. Mental Health and Physical Activity. 7: 37-41. PMID 24729793 DOI: 10.1016/J.Mhpa.2013.12.001 |
0.317 |
|
| 2014 |
Greer TL, Sunderajan P, Grannemann BD, Kurian BT, Trivedi MH. Does duloxetine improve cognitive function independently of its antidepressant effect in patients with major depressive disorder and subjective reports of cognitive dysfunction? Depression Research and Treatment. 2014: 627863. PMID 24563781 DOI: 10.1155/2014/627863 |
0.335 |
|
| 2014 |
Trivedi MH, Greer TL. Cognitive dysfunction in unipolar depression: implications for treatment. Journal of Affective Disorders. 152: 19-27. PMID 24215896 DOI: 10.1016/J.Jad.2013.09.012 |
0.438 |
|
| 2013 |
Rethorst CD, Sunderajan P, Greer TL, Grannemann BD, Nakonezny PA, Carmody TJ, Trivedi MH. Does exercise improve self-reported sleep quality in non-remitted major depressive disorder? Psychological Medicine. 43: 699-709. PMID 23171815 DOI: 10.1017/S0033291712001675 |
0.402 |
|
| 2013 |
Rethorst CD, Toups MS, Greer TL, Nakonezny PA, Carmody TJ, Grannemann BD, Huebinger RM, Barber RC, Trivedi MH. Pro-inflammatory cytokines as predictors of antidepressant effects of exercise in major depressive disorder. Molecular Psychiatry. 18: 1119-24. PMID 22925832 DOI: 10.1038/Mp.2012.125 |
0.466 |
|
| 2013 |
Greer TL, Sunderajan P, Grannemann BD, Trivedi MH. Cognitive and Psychosocial Improvements Following Aripiprazole Augmentation of SSRI Antidepressant Therapy in Treatment Refractory Depression: A Pilot Study Open Journal of Depression. 2: 45-53. DOI: 10.4236/OJD.2013.24010 |
0.314 |
|
| 2012 |
Stoutenberg M, Rethorst C, Fuzat G, Greer T, Blair S, Church T, Marcus B, Trivedi M. STimulant Reduction Intervention using Dosed Exercise (STRIDE) - Description of the Exercise Intervention and Behavioral Program to Ensure Adherence. Mental Health and Physical Activity. 5: 175-182. PMID 23667387 DOI: 10.1016/J.Mhpa.2012.08.003 |
0.365 |
|
| 2011 |
Trivedi MH, Greer TL, Grannemann BD, Church TS, Somoza E, Blair SN, Szapocznik J, Stoutenberg M, Rethorst C, Warden D, Ring KM, Walker R, Morris DW, Kosinski AS, Kyle T, et al. Stimulant reduction intervention using dosed exercise (STRIDE) - CTN 0037: study protocol for a randomized controlled trial. Trials. 12: 206. PMID 21929768 DOI: 10.1186/1745-6215-12-206 |
0.406 |
|
| 2011 |
Trivedi MH, Greer TL, Potter JS, Grannemann BD, Nunes EV, Rethorst C, Warden D, Ring KM, Somoza E. Determining the primary endpoint for a stimulant abuse trial: lessons learned from STRIDE (CTN 0037). The American Journal of Drug and Alcohol Abuse. 37: 339-49. PMID 21854276 DOI: 10.3109/00952990.2011.598589 |
0.371 |
|
| 2011 |
Trivedi MH, Greer TL, Church TS, Carmody TJ, Grannemann BD, Galper DI, Dunn AL, Earnest CP, Sunderajan P, Henley SS, Blair SN. Exercise as an augmentation treatment for nonremitted major depressive disorder: a randomized, parallel dose comparison. The Journal of Clinical Psychiatry. 72: 677-84. PMID 21658349 DOI: 10.4088/Jcp.10M06743 |
0.418 |
|
| 2011 |
Toups MS, Greer TL, Kurian BT, Grannemann BD, Carmody TJ, Huebinger R, Rethorst C, Trivedi MH. Effects of serum Brain Derived Neurotrophic Factor on exercise augmentation treatment of depression. Journal of Psychiatric Research. 45: 1301-6. PMID 21641002 DOI: 10.1016/J.Jpsychires.2011.05.002 |
0.406 |
|
| 2010 |
Greer TL, Kurian BT, Trivedi MH. Defining and measuring functional recovery from depression. Cns Drugs. 24: 267-84. PMID 20297853 DOI: 10.2165/11530230-000000000-00000 |
0.457 |
|
| 2010 |
McClintock SM, Husain MM, Greer TL, Cullum CM. Association between depression severity and neurocognitive function in major depressive disorder: a review and synthesis. Neuropsychology. 24: 9-34. PMID 20063944 DOI: 10.1037/A0017336 |
0.46 |
|
| 2009 |
Hughes CW, Trivedi MH, Cleaver J, Greer TL, Emslie GJ, Kennard B, Dorman S, Bain T, Dubreuil J, Barnes C. DATE: Depressed adolescents treated with exercise: Study rationale and design for a pilot study. Mental Health and Physical Activity. 2: 76-85. PMID 20454641 DOI: 10.1016/J.Mhpa.2009.09.005 |
0.47 |
|
| 2009 |
Greer TL, Trivedi MH. Exercise in the treatment of depression. Current Psychiatry Reports. 11: 466-72. PMID 19909669 DOI: 10.1007/S11920-009-0071-4 |
0.469 |
|
| 2006 |
Trivedi MH, Greer TL, Grannemann BD, Church TS, Galper DI, Sunderajan P, Wisniewski SR, Chambliss HO, Jordan AN, Finley C, Carmody TI. TREAD: TReatment with Exercise Augmentation for Depression: study rationale and design. Clinical Trials (London, England). 3: 291-305. PMID 16895046 DOI: 10.1191/1740774506Cn151Oa |
0.427 |
|
| 2006 |
Trivedi MH, Greer TL, Grannemann BD, Chambliss HO, Jordan AN. Exercise as an augmentation strategy for treatment of major depression. Journal of Psychiatric Practice. 12: 205-13. PMID 16883145 DOI: 10.1097/00131746-200607000-00002 |
0.398 |
|
| 2006 |
Chambliss HO, Greer TL, Grannemann BD, Jordan AN, Galper DI, Church TS, Trivedi MH, Blair SN. Baseline Physical Activity Characteristics of Individuals Seeking Exercise as an Adjuvant Treatment for Depression Medicine & Science in Sports & Exercise. 38: S98-S99. DOI: 10.1249/00005768-200605001-01336 |
0.446 |
|
| 2005 |
Greer TL, Trivedi MH, Thompson LT. Impaired delay and trace eyeblink conditioning performance in major depressive disorder. Journal of Affective Disorders. 86: 235-45. PMID 15935243 DOI: 10.1016/J.Jad.2005.02.006 |
0.645 |
|
| 2005 |
Trivedi MH, Kleiber B, Greer TL. Remission and recovery in depression treatment Drug Development Research. 65: 335-343. DOI: 10.1002/ddr.20034 |
0.352 |
|
| Show low-probability matches. |